Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; BCS; biopharmaceutics classification system; FFA; fenofibric acid; FFB; fenofibrate; HCO40; NIKKOL HCO-40; HCO60; NIKKOL HCO-60; HPLC; high performance liquid chromatography; M1944; Labrafil® M 1944CS;
مقالات ISI محدوده تحت منحنی زمان غلظت پلاسما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; anti-infectives; bioavailability; clinical pharmacokinetics; formulation; oral absorption; pharmacokinetics; HCV; hepatitis C virus; GT; genotype; DAA; direct-acting antiviral; RBV; ribavirin; GLE; glecaprevir; PIB; pibrentasvir; Cmax; maximum plasma conc
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; OTC; over the counter; AUC; area under the plasma concentration-time curve; AUMC; area under first moment of plasma drug concentration-time curve; MRT; mean residence time; Vdarea; apparent volume of distribution; CL; clearance; CYP; cytochrome; P-gp; P-g
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; Absorption; Amorphous; Bioavailability; Exposure; Gastric emptying; Intestinal motility; Pharmacokinetics; Variability; API; active pharmaceutical ingredient; AUC; area under the plasma concentration-time curve; BCS; biopharmaceutics classification system
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; B/P; blood-to-plasma ratio; CYP; cytochrome P450; CLint; intrinsic clearance; Cmax; maximum plasma concentration; CLPD; passive permeability-surface area product; DDI; drug-drug interaction; fa; fract
Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; botulism; botulinum neurotoxin; Human Botulism Immune Globulin; infant botulism; pentavalent botulinum toxoid; recombinant botulinum vaccine; AEs; adverse events; AUC; area under the plasma concentration-time curve; BIG-IV; Human Botulism Immune Globulin
Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; DSS; dextran sulphate sodium; UC; ulcerative colitis; GP; Ginseng polysaccharides; Rb1; ginsenoside Rb1; PPD; protopanaxadiol; CK; Compound K; PNPG; 4-nitrophenyl-β-D-glucopyranoside; DAI; disease activity index; MPO; myeloperoxidase; IL; interleukin; TN
Identification of novel quinazolinedione derivatives as RORγt inverse agonist
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; BA; bioavailability; EAE; experimental autoimmune encephalomyelitis; LBD; ligand-binding domain; RORγt; retinoic acid receptor-related orphan receptor-gamma t; SAR; structure-activity relationship; T
P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; BEI; biliary excretion index; CsA; cyclosporin A; DDI; drug-drug interaction; LC-MS/MS; liquid chromatography-tandem mass spectrometry; MDCKII cells; Madin-Darby canine kidney strain II cells; N
The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AM; Atractylodes macrocephala Koidz.; TCM; traditional Chinese medicine; UPLC; ultra-performance liquid chromatography; PDA; photo-diode array; IR; infrared spectroscopy; HS-LP-LPE; headspace liquid phase-liquid-phase extraction; GC-MS; gas chromatography
Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; AUCR; increase ratio in the area under the plasma concentration-time curve; BIM-I; bisindolylmaleimide I; BSP; sulfobromophthaleine; CCK8; cholecystokinine octapeptide; CsA; cyclosporin A; DDI; drug-dru
Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; physiologically based pharmacokinetic modeling; transporters; statin; absorption; organic anion-transporting polypeptide; drug-drug interaction; AUC; area under the plasma concentration-time curve; Cmax; maximum plasma concentration; CLint,T; transporter-
Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; active transport; cytochrome P450; glucuronosyltransferase (UGT); hepatic clearance; hepatic transport; hepatocytes; membrane transport/transporters; organic anion transporting polypeptide transporters; transporters; AUC; area under the plasma concentrati
Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; drug transport; drug interactions; organic anion-transporting polypeptide transporters; hepatocytes; hepatic transport; pharmacokinetics; physiologically based pharmacokinetic modeling; AUC; area under the plasma concentration-time curve; CsA; cyclosporin
Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; clinical pharmacokinetics; CYP enzymes; drug interaction; drug metabolizing enzymes; elimination; hepatic clearance; interspecies scaling; physiologically based pharmacokinetic modeling; preclinical pharmacokinetics; simulations; AUC; area under the plasm
A Physiologically Based Pharmacokinetic Model to Describe Artemether Pharmacokinetics in Adult and Pediatric Patients
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; clinical pharmacokinetics; CYP enzymes; drug metabolizing enzymes; elimination; hepatic clearance; interspecies scaling; physiologically based pharmacokinetic modeling; preclinical pharmacokinetics; simulations; AUC; area under the plasma concentration-ti
Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; drug interactions; in vitro/in vivo correlations; pharmacokinetics; protein binding; transporters; CYP enzymes; hepatocytes; organic anion-transporting polypeptide transporters; multidrug resistance transporters; solute transporters; ABT; 1-aminobenzotr
Research ArticlePharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; HCV; hepatitis C virus; Cmax; maximal plasma concentration; AUC; area under the plasma concentration-time curve; DAA; direct-acting antiviral agent; NS; nonstructural; CYP; cytochrome P450; Paritaprevir/r; paritaprevir administered with ritonavir; SVR12;
Research ArticleDrug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; PTV/r; paritaprevir/ritonavir; OBV; ombitasvir; DSV; dasabuvir; DAA; direct-acting antiviral agent; HCV; hepatitis C virus; Cmax; maximum observed plasma concentration; AUC; area under the plasma concentration-time curve; SVR; sustained virologic response
Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; ABC; ATP-binding cassette; ALK; anaplastic lymphoma kinase; AUC; area under the plasma concentration-time curve; BBB; blood-brain barrier; BCRP; breast cancer resistance protein; Cmax; maximum drug concentration in plasma; EML4; echinoderm microtubule-ass
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; LLOQ; lower limit of quantification; PARP; poly(ADP-ribose) polymerase; SRM; selected reaction monitoring; T1/2; elimination half-life; QC; quality control; Rucaparib; PARP inhibitor; LC-MS/MS; Plasma
Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; area under the plasma concentration-time curve; DDI; drug-drug interaction; CLint; intrinsic clearance; BCRP; Breast Cancer Resistance Protein; HEK293; Human Embryonic Kidney 293 (cell-line); MRP; Multidrug resistance-associated protein; NTCP; Sodi
Research ArticleAntiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AE; adverse event; ANOVA; analysis of variance; AUC; area under the plasma concentration-time curve; BMI; body mass index; Cmax; maximum observed plasma concentration; CHC; chronic hepatitis C; CLss/F; apparent total body clearance at steady state; DAA; d
Oral Ketamine for Children with Chronic Pain: A Pilot Phase 1 Study
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AUC; Area under the plasma concentration-time curve; CRM; Continual reassessment method; CYP; Cytochrome P450; DLT; Dose-limiting toxicity; DN4; Douleur Neuropathique 4; NOS; Not otherwise specified; NRS; Numerical rating scale;
Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; JBP485; cyclo-trans-4-l-hydroxyprolyl-l-serine; ARF; acute renal failure; Oat; organic anion transporters; Mrp2; multidrug resistance-associated protein 2; BUN; blood urea nitrogen; IS; indoxyl sulfate; PAH; para-aminohippurate; MDA; malondialdehyde; SOD;
Regular ArticleGlomerular filtration rate in patients with atrial fibrillation on warfarin treatment: A subgroup analysis from the AURICULA registry in Sweden
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; AF; atrial fibrillation; AUC; area under the plasma concentration-time curve; CKD; chronic kidney disease; CVD; cardiovascular disease; eGFR; estimated glomerular filtration rate; ESRD; end-stage renal disease; GFR; glomerular filtration rate; IDMS; isoto
UDP-glucuronosyltransferases and clinical drug-drug interactions
Keywords: محدوده تحت منحنی زمان غلظت پلاسما; UDP-glucuronosyltransferase; UGT1A; UGT2A; UGT2B; Glucuronidation; Drug interaction; Aet-ss; the amount of total drug excreted in urine during one dosage interval; AUCi; area under the plasma concentration-time curve in the presence of an inhibitor; AUC;